T Cell Impairment Is Predictive for a Severe Clinical Course in NEMO Deficiency.

MLA

Heller, Stephanie, et al. “T Cell Impairment Is Predictive for a Severe Clinical Course in NEMO Deficiency.” Journal of Clinical Immunology, vol. 40, no. 3, Apr. 2020, pp. 421–34. EBSCOhost, https://doi.org/10.1007/s10875-019-00728-y.

APA

Heller, S., Kölsch, U., Magg, T., Krüger, R., Scheuern, A., Schneider, H., Eichinger, A., Wahn, V., Unterwalder, N., Lorenz, M., Schwarz, K., Meisel, C., Schulz, A., Hauck, F., & von Bernuth, H. (2020). T Cell Impairment Is Predictive for a Severe Clinical Course in NEMO Deficiency. Journal of Clinical Immunology, 40(3), 421–434. https://doi.org/10.1007/s10875-019-00728-y

Chicago

Heller, Stephanie, Uwe Kölsch, Thomas Magg, Renate Krüger, Andrea Scheuern, Holm Schneider, Anna Eichinger, et al. 2020. “T Cell Impairment Is Predictive for a Severe Clinical Course in NEMO Deficiency.” Journal of Clinical Immunology 40 (3): 421–34. doi:10.1007/s10875-019-00728-y.